We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
351
CALL
Corbus Pharmaceuticals
CRBP
$190M
$22K ﹤0.01%
+18,617
New +$3.37M
PBR icon
352
CALL
Petrobras
PBR
$116B
$22K ﹤0.01%
+196,300
New +$1.67M
HTZ
353
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
$22K ﹤0.01%
149,500
-345,000
-70% -$497K
GNRSW
354
DELISTED
Greenrose Acquisition Corp. Warrant
GNRSW
$21K ﹤0.01%
88,059
-203,840
-70% -$50.3K
RIGL icon
355
CALL
Rigel Pharmaceuticals
RIGL
$797M
$19K ﹤0.01%
+3,750
New +$92.1K
WFC icon
356
Wells Fargo
WFC
$265B
$19K ﹤0.01%
+820
New +$20.2K
BTCTW
357
DELISTED
BTC Digital Ltd. Warrant
BTCTW
$19K ﹤0.01%
92,645
– –
BBIO icon
358
CALL
BridgeBio Pharma
BBIO
$16.3B
$18K ﹤0.01%
24,300
-15,700
-39% -$494K
JSPRW icon
359
Japer Therapeutics Warrants
JSPRW
$216K
$18K ﹤0.01%
15,000
– –
RF icon
360
CALL
Regions Financial
RF
$26.8B
$18K ﹤0.01%
30,000
– –
STLNW
361
Starling Oncology, Inc. Warrant
STLNW
$5.31M
$18K ﹤0.01%
+11,041
New +$18.1K
ALXN
362
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$18K ﹤0.01%
+27,000
New +$2.91M
ANDAR
363
DELISTED
Andina Acquisition Corp. III Right
ANDAR
$18K ﹤0.01%
49,995
+10,140
+25% +$3.84K
INO icon
364
CALL
Inovio Pharmaceuticals
INO
$78.3M
$17K ﹤0.01%
+8,200
New +$1.71M
NEM icon
365
PUT
Newmont
NEM
$125B
$17K ﹤0.01%
46,100
-2,800
-6% -$183K
V icon
366
Visa
V
$673B
$17K ﹤0.01%
+87
New +$17.4K
NHICW
367
DELISTED
NewHold Investment Corp. Warrant
NHICW
$17K ﹤0.01%
+25,000
New +$16.9K
CGROW
368
DELISTED
Collective Growth Corporation Warrant
CGROW
$17K ﹤0.01%
+28,058
New +$21.2K
BWA icon
369
PUT
BorgWarner
BWA
$14.4B
$16K ﹤0.01%
+23,742
New +$816K
CVX icon
370
CALL
Chevron
CVX
$385B
$16K ﹤0.01%
+20,000
New +$1.68M
DLR icon
371
PUT
Digital Realty Trust
DLR
$72.4B
$16K ﹤0.01%
25,500
+25,300
+12,650% +$3.79M
IONS icon
372
CALL
Ionis Pharmaceuticals
IONS
$9.31B
$16K ﹤0.01%
+16,500
New +$917K
GIK.WS
373
DELISTED
GigCapital3, Inc. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise
GIK.WS
$16K ﹤0.01%
+24,273
New +$13.7K
DLR icon
374
CALL
Digital Realty Trust
DLR
$72.4B
$15K ﹤0.01%
4,200
+2,800
+200% +$420K
QDEL icon
375
PUT
QuidelOrtho
QDEL
$980M
$15K ﹤0.01%
15,900
-12,300
-44% -$2.74M
13 14
15
16 17

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.